Total Payments
$22,357
2024 Payments
$118.06
Companies
8
Transactions
16
Medicare Patients
3,489
Medicare Billing
$318,460
Payment Breakdown by Category
Other$20,875 (93.4%)
Food & Beverage$865.57 (3.9%)
Travel$597.27 (2.7%)
Education$18.94 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $20,875 | 2 | 93.4% |
| Food and Beverage | $865.57 | 10 | 3.9% |
| Travel and Lodging | $597.27 | 3 | 2.7% |
| Education | $18.94 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SANOFI-AVENTIS U.S. LLC | $20,750 | 1 | $0 (2017) |
| NOVARTIS PHARMACEUTICALS CORPORATION | $1,163 | 9 | $0 (2021) |
| Genentech USA, Inc. | $125.00 | 1 | $0 (2019) |
| GENZYME CORPORATION | $125.00 | 1 | $0 (2021) |
| Alexion Pharmaceuticals, Inc. | $118.06 | 1 | $0 (2024) |
| EMD Serono, Inc. | $40.98 | 1 | $0 (2022) |
| US WorldMeds, LLC | $18.94 | 1 | $0 (2019) |
| MDD US Operations, LLC | $15.50 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $118.06 | 1 | Alexion Pharmaceuticals, Inc. ($118.06) |
| 2022 | $40.98 | 1 | EMD Serono, Inc. ($40.98) |
| 2021 | $322.67 | 5 | NOVARTIS PHARMACEUTICALS CORPORATION ($182.17) |
| 2019 | $540.43 | 4 | Novartis Pharmaceuticals Corporation ($396.49) |
| 2018 | $125.49 | 1 | Novartis Pharmaceuticals Corporation ($125.49) |
| 2017 | $21,209 | 4 | SANOFI-AVENTIS U.S. LLC ($20,750) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/09/2024 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $118.06 | General |
| 09/28/2022 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $40.98 | General |
| 10/26/2021 | MDD US Operations, LLC | APOKYN (Drug) | Food and Beverage | Cash or cash equivalent | $15.50 | General |
| Category: NEUROLOGY | ||||||
| 09/08/2021 | GENZYME CORPORATION | LEMTRADA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $125.00 | General |
| Category: Neurology | ||||||
| 08/28/2021 | NOVARTIS PHARMACEUTICALS CORPORATION | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: NEUROSCIENCE | ||||||
| 08/05/2021 | NOVARTIS PHARMACEUTICALS CORPORATION | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $95.40 | General |
| Category: NEUROSCIENCE | ||||||
| 02/04/2021 | NOVARTIS PHARMACEUTICALS CORPORATION | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $65.86 | General |
| Category: NEUROSCIENCE | ||||||
| 03/28/2019 | Genentech USA, Inc. | OCREVUS (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Immunology | ||||||
| 03/07/2019 | US WorldMeds, LLC | Xadago (Drug) | Education | In-kind items and services | $18.94 | General |
| Category: Neurology | ||||||
| 01/25/2019 | Novartis Pharmaceuticals Corporation | — | Travel and Lodging | In-kind items and services | $266.81 | General |
| 01/25/2019 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $129.68 | General |
| 04/24/2018 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Food and Beverage | In-kind items and services | $125.49 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2017 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Travel and Lodging | In-kind items and services | $185.75 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2017 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Travel and Lodging | Cash or cash equivalent | $144.71 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2017 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Food and Beverage | In-kind items and services | $128.69 | General |
| Category: NEUROSCIENCE | ||||||
| 06/13/2017 | SANOFI-AVENTIS U.S. LLC | LEMTRADA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $20,749.84 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 926 | 1,483 | $674,125 | $85,393 |
| 2022 | 14 | 888 | 1,427 | $652,227 | $86,047 |
| 2021 | 12 | 819 | 1,294 | $524,057 | $77,807 |
| 2020 | 15 | 856 | 1,333 | $509,746 | $69,213 |
Total Patients
3,489
Total Services
5,537
Medicare Billing
$318,460
Procedure Codes
59
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 253 | 480 | $235,200 | $31,594 | 13.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 116 | 120 | $70,800 | $11,172 | 15.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 160 | 209 | $68,970 | $9,184 | 13.3% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 94 | 242 | $56,870 | $8,728 | 15.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 73 | 125 | $46,250 | $7,375 | 15.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 77 | 77 | $55,440 | $6,971 | 12.6% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Facility | 2023 | 18 | 42 | $56,700 | $3,367 | 5.9% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 29 | 36 | $15,480 | $1,475 | 9.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 12 | 12 | $8,280 | $1,310 | 15.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 11 | 11 | $9,625 | $1,195 | 12.4% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2023 | 22 | 36 | $18,540 | $1,184 | 6.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2023 | 23 | 29 | $6,670 | $641.72 | 9.6% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2023 | 11 | 12 | $4,680 | $520.68 | 11.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 16 | 34 | $16,660 | $420.45 | 2.5% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Facility | 2023 | 11 | 18 | $3,960 | $255.85 | 6.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 255 | 532 | $247,380 | $36,853 | 14.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 180 | 236 | $73,868 | $10,660 | 14.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 64 | 157 | $55,735 | $8,365 | 15.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 83 | 83 | $57,021 | $7,371 | 12.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 57 | 58 | $32,995 | $5,364 | 16.3% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Facility | 2022 | 15 | 40 | $52,000 | $3,233 | 6.2% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2022 | 40 | 71 | $35,500 | $2,479 | 7.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 21 | 21 | $13,818 | $2,464 | 17.8% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 41 | 71 | $16,330 | $2,081 | 12.7% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 43 | 43 | $18,060 | $1,905 | 10.6% |
About Dr. James Napier, MD
Dr. James Napier, MD is a Internal Medicine healthcare provider based in Green Bay, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1043327489.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Napier, MD has received a total of $22,357 in payments from pharmaceutical and medical device companies, with $118.06 received in 2024. These payments were reported across 16 transactions from 8 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($20,875).
As a Medicare-enrolled provider, Napier has provided services to 3,489 Medicare beneficiaries, totaling 5,537 services with total Medicare billing of $318,460. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Neurology
- Location Green Bay, WI
- Active Since 08/23/2006
- Last Updated 10/09/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1043327489
Products in Payments
- LEMTRADA (Drug) $20,750
- GILENYA (Drug) $584.64
- KESIMPTA (Drug) $182.17
- LEMTRADA (Biological) $125.00
- OCREVUS (Biological) $125.00
- Xadago (Drug) $18.94
- APOKYN (Drug) $15.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Green Bay
Dr. Prabhpreet Singh, M.d, M.D
Internal Medicine — Payments: $51,603
Internal Medicine $51,603
Prince Ntiamoah, Md, MD
Internal Medicine — Payments: $36,345
Internal Medicine $36,345
Abdul Safadi, M.d, M.D
Internal Medicine — Payments: $32,936
Internal Medicine $32,936
Dr. Sampoornima Setty, M.d, M.D
Internal Medicine — Payments: $15,643
Internal Medicine $15,643
Dr. Aliaksandr Trusau, M.d, M.D
Internal Medicine — Payments: $15,233
Internal Medicine $15,233
Dr. Jennifer Davis, M.d, M.D
Internal Medicine — Payments: $12,209
Internal Medicine $12,209